Dreismann Heinrich's Form 4 filing
Myriad Genetics Inc (MYGN) · filed Sep 9, 2024
- Accession no.
- 0001379372-24-000002
- Filed
- Sep 9, 2024
- Trade date
- Sep 9, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $270.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dreismann HeinrichCIK 0001379372 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | Common Stock | SSaleDisposed | −10,000 | $27.05 | −$270,500 | 121,648 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.